FMOD and breast carcinoma: We find for the first time that in breast cancer cells FMOD expression is regulated positively by the Wnt/β-catenin signaling pathway, and FMOD is transcribed by the β-catenin/TCF4/LEF1 transcription complex which binds to the FMOD promoter at specific sites.